Targeted Bottom-up Characterization of Recombinant Monoclonal Antibodies by Multidimensional LC/MS
- 6 October 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 92 (19), 13420-13426
- https://doi.org/10.1021/acs.analchem.0c02780
Abstract
On-line bottom-up approaches have recently emerged as promising alternatives to standard off-line processes for characterizing post-translational modifications (PTMs) of therapeutic monoclonal antibodies (mAbs). The benefits of on-line processing include reductions in required sample amount and sample handling, as well as reducing the overall turnaround time. However, shortening digestion time for the on-line approach of an intact mAb can cause incomplete peptide cleavages, leading to low sequence coverage and poor repeatability of analyses. For the first time, we describe a novel, automated targeted bottom-up strategy consisting of reducing the complexity of intact mAb by digesting the product into small similar to 25 kDa fragments, followed by an on-line peptide mapping analysis of each fragment. For this purpose, a four-dimensional-liquid chromatography/mass spectrometry (4D-LC/MS) method was developed using an immobilized IdeS-high-performance liquid chromatography (HPLC) column as a first dimension (D-1) for on-line digestion, followed by a (D-2) on-column reversed-phase liquid chromatography (RPLC) for reduction and fragments separation. Then, only one fragment was selected for digestion using a (D-3) immobilized trypsin cartridge and, finally, the obtained peptides were analyzed by (D-4) RPLC-MS. This strategy considerably improved the on-line digestion efficiency with higher sequence coverages (LC and HC >97%), thus allowing various PTMs including oxidation, deamidation, and isomerization located in the complementarity-determining regions (CDRs), as well as N-glycans present on the Fc/2 fragment, to be monitored with similar sensitivity to those obtained with standard off-line approaches. Additional investigations at a middle-up level were also performed via a three-dimensional-LC/MS (3D-LC/MS) approach within the same system, demonstrating the feasibility to achieve a multilevel comprehensive characterization of mAbs.This publication has 23 references indexed in Scilit:
- Development of Immobilized Enzyme Reactors for the characterization of the glycosylation heterogeneity of a proteinTalanta, 2020
- Structure, heterogeneity and developability assessment of therapeutic antibodiesmAbs, 2018
- Determination of critical quality attributes for monoclonal antibodies using quality by design principlesBiologicals, 2016
- Chromatographic, Electrophoretic, and Mass Spectrometric Methods for the Analytical Characterization of Protein BiopharmaceuticalsAnalytical Chemistry, 2015
- Selective Oxidation of Methionine and Tryptophan Residues in a Therapeutic IgG1 MoleculeJournal of Pharmaceutical Sciences, 2015
- Fc glycans of therapeutic antibodies as critical quality attributesGlycobiology, 2015
- Characterization of Therapeutic Antibodies and Related ProductsAnalytical Chemistry, 2012
- Systematic and quantitative comparison of digest efficiency and specificity reveals the impact of trypsin quality on MS-based proteomicsJournal of Proteomics, 2012
- Identification of isomerization and racemization of aspartate in the Asp–Asp motifs of a therapeutic proteinAnalytical Biochemistry, 2011
- Glycosylation as a strategy to improve antibody-based therapeuticsNature Reviews Drug Discovery, 2009